Filip Szymański

Dr. Filip Szymański


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
ACAleksandra Czerw
Aleksandra Czerw
Urszula ReligioniUrszula Religioni
Urszula Religioni
FSFilip Szymański
Filip Szymański
ANAgnieszka Nieradko-Heluszko
Agnieszka Nieradko-Heluszko
DMDominika Mękal
Dominika Mękal
MPMonika Pajewska
Monika Pajewska
Cancer is associated with discomfort and many changes in patients’ lives to which they must adapt. The main objective of the study was to assess the use of the mini-MAC questionnaire scale among persons diagnosed with malignant cancer and to develop standards allowing differentiation of patients with diagnosed cancer in terms of their style of adjustment to the disease. The mini-MAC questionnaire is a widely used tool in assessing coping strategies among cancer patients. Sten standards have been developed to determine the level of results on the questionnaire scales in the low–average–high categories. The study included 1187 patients diagnosed with malignant cancer who are covered by outpatient care at the Maria Sklodowska-Curie Institute—Oncology Center in Warsaw. The questionnaire concerning mental adjustment to cancer was used (mini-MAC). Patients with cancer most often adopt strategies of fighting spirit and positive reevaluation. The variables that differentiate the results most significantly include gender, presence of metastasis, and the state of undergoing chemotherapy. The mini-MAC questionnaire should be a tool for psycho-oncological diagnosis of patients’ attitudes towards cancer. The obtained results indicate that cancer patients are characterized by their constructive style of adjustment to the disease.

1 January 2021 in Central European Journal of Urology
Verified
Journal Article
Open access
KSKarolina Semczuk-Kaczmarek
Karolina Semczuk-Kaczmarek
ARAnna Rys-Czaporowska
Anna Rys-Czaporowska
APAnna E. Platek
Anna E. Platek
FSFilip Szymański
Filip Szymański
The Central European Journal of Urology is an open access quarterly-issued journal, which provides a forum for the presentation of original clinical, experimental and other research studies...

13 May 2021 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
FSFilip Szymański
Filip Szymański
KSKarolina Semczuk-Kaczmarek
Karolina Semczuk-Kaczmarek
PKPiotr Kuna
Piotr Kuna

ACAleksandra Czerw
Aleksandra Czerw
Urszula ReligioniUrszula Religioni
Urszula Religioni
FSFilip Szymański
Filip Szymański
KSKatarzyna Sygit
Katarzyna Sygit
KZKrzysztof Zdziarski
Krzysztof Zdziarski
MPMonika Pajewska
Monika Pajewska
The purpose of this article is to examine the applicability of the Beliefs about Pain Control Questionnaire (BPCQ) among cancer patients and develop norms that allow differentiation of patients with diagnosed cancer in terms of beliefs about pain control. Normalization aims to establish the value of test results in the study population. The study involved 1187 patients diagnosed with cancer in outpatient care Maria Sklodowska-Curie Cancer Center and Institute of Oncology, in Warsaw. The applied tool was the Beliefs about Pain Control Questionnaire developed by S. Skevington. The results are most strongly differentiated in each dimension of pain control by education, income, and professional status. Sten norms were developed to determine the level of beliefs about pain control in low, average, and high categories. The BPCQ assessment applies to cancer patients, and the assessment of the location of pain control in patients will allow for the identification of patients whose standard therapy should be supplemented with psychotherapeutic support.

KGKatarzyna Grzyb
Katarzyna Grzyb
MMMartyna Meresińska
Martyna Meresińska
Urszula ReligioniUrszula Religioni
Urszula Religioni
GJGrzegorz Piotr Juszczyk
Grzegorz Piotr Juszczyk
JPJakub Płaczek
Jakub Płaczek
Piotr MerksPiotr Merks
Piotr Merks
Background: Non-adherence occurs in various groups of patients, including those with chronic diseases. One strategy to increase adherence among oncological patients is to individualise treatment and expand pharmaceutical care. Pharmaceutical labels that remind patients how they should take their medications are of great importance in this respect. Objective: The main objective of this study was to evaluate medication adherence in oncological patients, and to gather their opinions on the individual medication labelling system as an element of effective treatment. Methods: The study was conducted in 2021 among 82 patients of the oncological department of the Centre of Oncology in Radom. The research tool was a questionnaire consisting of personal data and two parts relating to the patient’s disease and the medication labelling system. Results: Nearly half of the respondents reported that they forget to take medications and how they should take them. These problems increased with the age of the patient and the number of administered medications. Of the respondents, 89% stated that the labels with dosing information are helpful. Over 67% agreed that these labels should be affixed to all medications. Nearly 90% of the respondents believed the labels should be available in all pharmacies. Conclusions: Non-adherence is a common phenomenon among oncological patients. Pharmacists providing a labelling service for medicinal products can play a significant role in reducing this phenomenon.